5 months ago
NBIX
AnalystsJeffrey WalchJeffrey Walch's Stock Forecasts
AnalystsJeffrey Walch
Sectors:
Analyst Ranking
Top 50%
#2755 out of 5536 analysts
Average Return
+10.26%
Win Rate
67%2 out of 3
Risk vs Reward
Poor
Good
Jeffrey Walch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nuvalent IncNUVL | +21.01% | $102.12 | $123.58 | 2026-05-22 - 2026-06-24 | Buy |
Summit Therapeutics IncSMMT | +19.61% | $16.62 | $13.36 | 2026-05-22 - 2026-08-25 | Sell |
Jeffrey Walch Analyst Color
Get additional color on Jeffrey Walch's coverage of popular stocks
5 months ago
JAZZ
Jeffrey Walch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | 2 | Hold | $11.90 | -30.69% | Upgrades | a month ago |
Revolution Medicines IncRVMD | 2 | Hold | $179.00 | -4.85% | Maintains | 2 months ago |
Nuvalent IncNUVL | 2 | Hold | $124.00 | +0.03% | Downgrades | 4 months ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $221.00 | +56.46% | Initiates Coverage On | 5 months ago |
Incyte CorpINCY | 1 | Hold | $99.00 | -12.20% | Initiates Coverage On | 5 months ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Hold | $229.00 | +2.94% | Initiates Coverage On | 5 months ago |
Biontech SeBNTX | 1 | Hold | $96.00 | +4.28% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.